Immunic AG

7 trials 3 recruiting Commercial sponsor

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

3 Recruiting

4 Completed trials

9 Countries active

1 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I (Other)

Phase III: 2 Phase II: 2 Phase I (Other): 3

100%

4 of 4 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Multiple sclerosis 3 Relapsing multiple sclerosis 2 Relapsing-remitting multiple sclerosis 1 Progressive multiple sclerosis 1

Top IMPs

VIDOFLUDIMUS CALCIUM 4

All trials

7 total

Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with P… Recruiting

2024-514617-35-00 Phase II 6 countries VIDOFLUDIMUS CALCIUM
Randomized, double-blind, placebo-controlled, multicenter Phase 2 trial assessing the effect of IMU-838 on disease activity, as measured by … Recruiting

2024-516739-29-00 Phase II 4 countries VIDOFLUDIMUS CALCIUM
A Phase 1, drug-drug interaction trial of IMU-838 with oral contraceptives in women Recruiting

2026-525208-90-00 Phase I (Other) 1 country
A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adu… Ended

2024-514619-88-00 Phase III 4 countries VIDOFLUDIMUS CALCIUM
A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adu… Ended

2024-514618-11-00 Phase III 4 countries VIDOFLUDIMUS CALCIUM
A study investigating the effect of curcumin on the absorption and elimination of IMU 838, a new compound that may potentially be used in th… Ended

2025-523791-24-00 Phase I (Other) 1 country
A Phase 1, Single-Center, Open-Label, Fixed-Sequence, 2-Part Study to Assess the Pharmacokinetics of IMU-838 Administered Alone and in Combi… Ended

2025-521754-41-00 Phase I (Other) 1 country

Showing 1–7 of 7 trials

← All sponsors A–Z